Jones James bought CPIX
August 8, 2025 · Form 4 insider transaction
Jones James bought 13 shares of Cumberland Pharmaceuticals Inc. at $3.39 per share, a transaction worth $44.07. The trade was recorded as open-market purchase under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 35 days after the transaction.
Direction
Acquired (buy-side)
Shares
13
Price
$3.39
Total value
$44.07
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateAugust 8, 2025
Filing dateSeptember 12, 2025
Shares owned after43,754
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024.